Epoch 29 - Forecasting a Biotech Return to Normalcy

Alternative Metrics to Diagnose Market Health

Hello Avatar! Welcome back for another week of biotech analysis.  This week we have a fun non-traditional analysis which aims to quantitate market conditions.  We all are hyper aware the market has been decimated in 2022, but also that we are in the midst of a nice rally.  Where do we go next?  Some are of the position we have bottomed, others see anoth…